# Correction: From guidelines to evidence-based practice – A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis

**Authors:** Elisabeth Schnoy, Axel Dignass, Matthew Gaskins, Torsten Kucharzik

PMC · DOI: 10.1055/a-2832-4215 · Zeitschrift Fur Gastroenterologie · 2026-03-13

## Full-text entities

- **Diseases:** ulcerative colitis (MESH:D003093)
- **Chemicals:** Salofalk Granu-Stix (-), Asacol (MESH:D019804)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12987698/full.md

---
Source: https://tomesphere.com/paper/PMC12987698